These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 19525261

  • 1. Targeting abdominal obesity and the metabolic syndrome to manage cardiovascular disease risk.
    Després JP.
    Heart; 2009 Jul; 95(13):1118-24. PubMed ID: 19525261
    [No Abstract] [Full Text] [Related]

  • 2. Unmet needs in controlling metabolic disease.
    Haffner SM.
    Rev Cardiovasc Med; 2007 Jul; 8 Suppl 4():S17-24. PubMed ID: 17934390
    [Abstract] [Full Text] [Related]

  • 3. The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology.
    Després JP, Cartier A, Côté M, Arsenault BJ.
    Ann Med; 2008 Jul; 40(7):514-23. PubMed ID: 18608131
    [Abstract] [Full Text] [Related]

  • 4. Cardiovascular outcomes for obesity and metabolic syndrome.
    Vega GL.
    Obes Res; 2002 Nov; 10 Suppl 1():27S-32S. PubMed ID: 12446855
    [No Abstract] [Full Text] [Related]

  • 5. New insights into understanding cardiometabolic risk. Introduction.
    Fonarow GC, Watson KE.
    Rev Cardiovasc Med; 2007 Nov; 8 Suppl 4():S1-2. PubMed ID: 17934389
    [No Abstract] [Full Text] [Related]

  • 6. The progression of cardiovascular risk to cardiovascular disease.
    Rosin BL.
    Rev Cardiovasc Med; 2007 Nov; 8 Suppl 4():S3-8. PubMed ID: 17934392
    [Abstract] [Full Text] [Related]

  • 7. [Enlarged waist circumference and cardiovascular risk factors].
    Pataky Z, Bobbioni-Harsch E, Makoundou V, Golay A.
    Rev Med Suisse; 2009 Mar 25; 5(196):671-2, 674-5. PubMed ID: 19462610
    [Abstract] [Full Text] [Related]

  • 8. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.
    Klein S, Burke LE, Bray GA, Blair S, Allison DB, Pi-Sunyer X, Hong Y, Eckel RH, American Heart Association Council on Nutrition, Physical Activity, and Metabolism.
    Circulation; 2004 Nov 02; 110(18):2952-67. PubMed ID: 15509809
    [Abstract] [Full Text] [Related]

  • 9. Metabolic syndrome, abdominal obesity, and cardiovascular risk in elderly women.
    Cabrera MA, Gebara OC, Diament J, Nussbacher A, Rosano G, Wajngarten M.
    Int J Cardiol; 2007 Jan 08; 114(2):224-9. PubMed ID: 16784787
    [Abstract] [Full Text] [Related]

  • 10. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes.
    Haffner SM.
    Obesity (Silver Spring); 2006 Jun 08; 14 Suppl 3():121S-127S. PubMed ID: 16931493
    [Abstract] [Full Text] [Related]

  • 11. Abdominal adiposity and cardiometabolic risk: do we have all the answers?
    Haffner SM.
    Am J Med; 2007 Sep 08; 120(9 Suppl 1):S10-6; discussion S16-7. PubMed ID: 17720354
    [Abstract] [Full Text] [Related]

  • 12. [Obesity and the metabolic syndrome--more questions than answers?].
    Sucharda P.
    Vnitr Lek; 2007 Apr 08; 53(4):441-3. PubMed ID: 17578181
    [No Abstract] [Full Text] [Related]

  • 13. Metabolic complications of obesity: inflated or inflamed?
    Chandalia M, Abate N.
    J Diabetes Complications; 2007 Apr 08; 21(2):128-36. PubMed ID: 17331862
    [Abstract] [Full Text] [Related]

  • 14. Use of the metabolic syndrome in pediatrics: a blessing and a curse.
    Battista M, Murray RD, Daniels SR.
    Semin Pediatr Surg; 2009 Aug 08; 18(3):136-43. PubMed ID: 19573755
    [Abstract] [Full Text] [Related]

  • 15. Optimal diabetes management during medical weight loss for cardiovascular risk reduction.
    Nori Janosz KE, Miller WM, Odom J, Lillystone M, McCullough PA.
    Expert Rev Cardiovasc Ther; 2005 Jul 08; 3(4):761-75. PubMed ID: 16076284
    [Abstract] [Full Text] [Related]

  • 16. Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity.
    Song SH, Hardisty CA.
    QJM; 2008 Nov 08; 101(11):875-9. PubMed ID: 18776208
    [Abstract] [Full Text] [Related]

  • 17. Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction.
    Lee M, Aronne LJ.
    Am J Cardiol; 2007 Feb 19; 99(4A):68B-79B. PubMed ID: 17307059
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular risk in the spectrum of type 2 diabetes mellitus.
    Ahmed I, Goldstein BJ.
    Mt Sinai J Med; 2006 Sep 19; 73(5):759-68. PubMed ID: 17008936
    [Abstract] [Full Text] [Related]

  • 19. Obesity and metabolic disease.
    Koopman RJ, Swofford SJ, Beard MN, Meadows SE.
    Prim Care; 2009 Jun 19; 36(2):257-70. PubMed ID: 19501242
    [Abstract] [Full Text] [Related]

  • 20. Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction.
    Sacks FM.
    Am J Cardiol; 2008 Dec 22; 102(12A):1L-3L. PubMed ID: 19084082
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.